Literature DB >> 27454657

Allogeneic hematopoietic cell transplant for patients with end stage renal disease requiring dialysis - a single institution experience.

Mazyar Shadman1,2, Sangeeta Hingorani1,3, Scott A Lanum4, John M Pagel1,2, Rainer Storb1,2, David G Maloney1,2, Brenda M Sandmaier1,2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27454657      PMCID： PMC5378061          DOI： 10.1080/10428194.2016.1211280

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  13 in total

1.  Allogeneic stem cell transplant in renal failure: engraftment and prolonged survival, but high incidence of neurologic toxicity.

Authors:  Koen van Besien; Viviane Schouten; Sandeep Parsad; Sonali Smith; Olatoyosi Odenike; Andrew S Artz
Journal:  Leuk Lymphoma       Date:  2011-09-06

Review 2.  Preparative regimen dosing for hematopoietic stem cell transplantation in patients with chronic kidney disease: analysis of the literature and recommendations.

Authors:  Megan N Bodge; Srividya Reddy; Michael Scott Thompson; Bipin N Savani
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-22       Impact factor: 5.742

3.  Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.

Authors:  Marion Haubitz; Frank Bohnenstengel; Reinhard Brunkhorst; Matthias Schwab; Ute Hofmann; Dagmar Busse
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

Review 4.  Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders.

Authors:  Frédéric Baron; Rainer Storb
Journal:  Mol Ther       Date:  2005-11-08       Impact factor: 11.454

Review 5.  Management of hematological malignancies in patients affected by renal failure.

Authors:  Pasquale Niscola; Gisella Vischini; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Francesco Bondanini; Claudio Romani; Gregorio Antonio Brunetti; Claudio Cartoni; Luca Cupelli; Michele Ferrannini; Alessio Perrotti; Giovanni Del Poeta; Roberto Palumbo; Paolo de Fabritiis
Journal:  Expert Rev Anticancer Ther       Date:  2011-03       Impact factor: 4.512

6.  Administration and pharmacokinetics of high-dose cyclophosphamide with hemodialysis support for allogeneic bone marrow transplantation in acute leukemia and end-stage renal disease.

Authors:  J J Perry; R A Fleming; M V Rocco; W P Petros; A J Bleyer; J E Radford; B L Powell; D D Hurd
Journal:  Bone Marrow Transplant       Date:  1999-04       Impact factor: 5.483

7.  Dialysate concentration and pharmacokinetics of 2F-Ara-A in a patient with acute renal failure.

Authors:  Jan T Kielstein; Michael Stadler; David Czock; Frieder Keller; Bernd Hertenstein; Jörg Radermacher
Journal:  Eur J Haematol       Date:  2005-06       Impact factor: 2.997

8.  Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

Authors:  Sergio A Giralt; Charles F LeMaistre; Navneet S Majhail; Stephanie H Farnia; Paul A Carpenter; Richard E Champlin; Stephen Crawford; David I Marks; James L Omel; Paul J Orchard; Jeanne Palmer; Wael Saber; Bipin N Savani; Paul A Veys; Christopher N Bredeson
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-07       Impact factor: 5.742

9.  The pharmacokinetics and pharmacodynamics of fludarabine phosphate in patients with renal impairment: a prospective dose adjustment study.

Authors:  Stuart M Lichtman; Erlinda Etcubanas; Daniel R Budman; Peter Eisenberg; George Zervos; Paul D'Amico; Vivian O'Mara; Kimberly Musgrave; Peter Cascella; Armen Melikian; Peter H Hinderling; Jorge M Ferrer; Gary J Williams
Journal:  Cancer Invest       Date:  2002       Impact factor: 2.176

10.  Successful allogeneic blood stem cell transplantation for aplastic anemia in a patient with renal insufficiency requiring dialysis.

Authors:  T Hamaki; H Katori; M Kami; T Yamato; H Yamakado; T Itoh; E Kusumi; M Igarashi; J Ueyama; Y Kanda; S Miyakoshi; S Mineishi; S Morinaga; M Mukai; M Hayashi; Y Takaue; S Hara; Y Mutou
Journal:  Bone Marrow Transplant       Date:  2002-08       Impact factor: 5.483
View more
  3 in total

1.  Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

Authors:  Nosha Farhadfar; Ajoy Dias; Tao Wang; Caitrin Fretham; Saurabh Chhabra; Hemant S Murthy; Larisa Broglie; Anita D'Souza; Shahinaz M Gadalla; Robert Peter Gale; Shahrukh Hashmi; A Samer Al-Homsi; Gerhard C Hildebrandt; Peiman Hematti; David Rizzieri; Lynette Chee; Hillard M Lazarus; Christopher Bredeson; Edgar A Jaimes; Amer Beitinjaneh; Asad Bashey; Tim Prestidge; Maxwell M Krem; David I Marks; Stefanie Benoit; Jean A Yared; Taiga Nishihori; Richard F Olsson; Cesar O Freytes; Edward Stadtmauer; Bipin N Savani; Mohamed L Sorror; Siddhartha Ganguly; John R Wingard; Marcelo Pasquini
Journal:  Transplant Cell Ther       Date:  2021-02-26

2.  Chemotherapy for non-Hodgkin lymphoma in the hemodialysis patient: A comprehensive review.

Authors:  Hajime Yasuda; Mutsuko Yasuda; Norio Komatsu
Journal:  Cancer Sci       Date:  2021-06-11       Impact factor: 6.716

3.  Delayed kidney transplantation after HLA-haploidentical hematopoietic cell transplantation in a young woman with myelodysplastic syndrome with renal failure.

Authors:  Kevin C Miller; Aric C Hall; Abraham Cohen-Bucay; Yi-Bin Chen
Journal:  Leuk Res Rep       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.